Skip to main content

Jamie Reed Protecting Our Kids from Child Abuse Act (H.R. 4618)

Referred to Committee
Introduced 7/22/2025•119th Congress•House

Latest Action

Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

7/22/2025 • House

Summary

Jamie Reed Protecting Our Kids from Child Abuse Act

This bill makes certain health care facilities and medical practitioners liable for any physical or mental harm caused by performing a gender-transition procedure on an individual younger than age 18. The liability extends for 30 years after the individual who received the procedure turns 18, and it applies to procedures occurring before, on, or after the bill's date of enactment.

Specifically, the liability applies to

  • pediatric gender clinics (medical facilities specializing in the diagnosis and treatment of gender discordance and dysphoria in minors) that provide gender-transition procedures;
  • institutions of higher education and hospitals affiliated with those clinics, and
  • medical practitioners who perform gender-transition procedures or administer health care related to the procedures at pediatric gender clinics.

Medical practitioners and health care facilities may defend against a liability claim if they neither knew nor had reason to know the individual was a minor.

Additionally, the bill prohibits federal funding for (1) gender-transition procedures performed on minors, (2) pediatric gender clinics, and (3) institutions of higher education or hospitals affiliated with those clinics.

Under the bill, gender-transition procedures generally include surgeries or hormone therapies that change the body of an individual to correspond to a sex that is different than the individual's biological sex. These exclude, however, specified types of interventions, including those that address (1) ambiguous biological sex characteristics or abnormal sex chromosome structure or hormones; or (2) infections or other harms that result from a gender-transition procedure. 

Introduced in House • 7/22/2025

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Child healthCivil actions and liabilityDrug therapyHealth facilities and institutionsHealth personnelHealth programs administration and fundingHigher educationPrescription drugsSex, gender, sexual orientation discriminationSurgery and anesthesia

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

0
Democrats
2
Republicans
0
Independents

Sponsor

R[
Rep. Steube, W. Gregory [R-FL-17]

Republican • FL-17

Sponsored 7/22/2025

Cosponsors (1)

R[
Rep. Miller, Mary E. [R-IL-15]

R-IL-15

Joined 7/22/2025

Bill Journey

Originated in the House

Introduced

July 22, 2025

Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House7/22/2025

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors1

Sources and method

AI-written text on this page is labeled where it appears. It is written from the sources above and is not a source itself. How we analyze data →

Dates shown where the source reports one. “Loaded” is when CIV.IQ last fetched the record.